Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury.
D015761:4-Aminopyridine / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D000293:Adolescent; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D026902:Potassium Channel Blockers / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D013119:Spinal Cord Injuries / Q000188:drug therapy* / Q000378:metabolism
D003692:Delayed-Action Preparations; D026902:Potassium Channel Blockers; D015761:4-Aminopyridine